Stanford Medicine
Robert A. Bradway is Amgen’s Chairman and Chief Executive Officer. Bob became Chairman in January 2013 and Chief Executive Officer in May 2012. Bob served as the company’s President and Chief Operating Officer from May 2010 to May 2012 and was appointed to the Amgen Board of Directors in October 2011. He joined the company in 2006. Prior to joining Amgen, he was a Managing Director at Morgan Stanley in London.
Bob holds a bachelor’s degree in biology from Amherst College and an MBA from Harvard University. He is a member of the board of directors of The Boeing Company. Bradway serves on the board of trustees of the University of Southern California and on the advisory board of the Leonard D. Schaeffer Center for Health Policy and Economics at that university.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Stanford Medicine
Stanford Medicine improves health through leadership, diversity, and collaborative discoveries and innovation in health care, education, and research. The Stanford School of Medicine is a premier setting for integrated research, medical education, and clinical care. As the academic hub of Stanford Medicine, which also comprises adult and pediatric healthcare delivery systems, it fuels discovery and innovation to advance human health while empowering the medical and scientific leaders of tomorrow. Learn more at med.stanford.edu/school.